High Content Screening
Fluofarma has developed a High Content Screening (HCS) technology that improves the level of understanding of compounds and their effects, from the earliest stage of the discovery process onwards.
Base of HCS
High Content Screening is a powerful automated cell biology method that enables the functional analysis of several molecular events simultaneously in living cells. Key parameters to identify, select and characterize innovative compounds are measured by automated 96-well plate flow cytometry.
Breaking news
Scientific Publication
Fluofarma is glad to announce a new scientific publication in the Journal of Cell Science.Read more [+]
SMi's Cell-Based Assays 2008
Fluofarma will be attending SMi's Cell-Based Assays conference, in London from November 19th to 20th.Read more [+]
GDDI Forum 2009
Fluofarma will be attending Global Discovery & Development Innovation Forum 2009, in London, from March 2nd to 3rd.Read more [+]
Career opportunities:
Fluofarma is searching for new talents, currently several
positions are available:
- Research Associates
- Bioengineers
Read more [+]